CN Patent

CN116836132A — 一种沃替西汀氢溴酸盐晶型h及其制备方法和用途

Assigned to Zhejiang Huahai Pharmaceutical Co Ltd · Expires 2023-10-03 · 3y expired

What this patent protects

本发明提供了一种沃替西汀氢溴酸晶型H以及其制备方法和用途。本发明通过在有机溶剂加热溶清直接浓缩得所述晶型。本发明的晶型制备方法简单，且该得到的晶型具有良好的化学稳定性和物理稳定性。本发明还涉及含有治疗有效量的晶型H的药物组合物和其在制备治疗抑郁症药物中的应用。

USPTO Abstract

本发明提供了一种沃替西汀氢溴酸晶型H以及其制备方法和用途。本发明通过在有机溶剂加热溶清直接浓缩得所述晶型。本发明的晶型制备方法简单，且该得到的晶型具有良好的化学稳定性和物理稳定性。本发明还涉及含有治疗有效量的晶型H的药物组合物和其在制备治疗抑郁症药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN116836132A
Jurisdiction
CN
Classification
—
Expires
2023-10-03
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Huahai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.